Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

For Physicians

Clinician Education

  • Opportunities for Our Referring Physicians

    team of clinicians

    Dana-Farber Cancer Institute is a principal teaching affiliate of Harvard Medical School. Through continuing medical education (CME) and continuing educational unit (CEU) courses, we share advances in cancer research and treatment with the health care community. We also provide educational programs for nurse practitioners, nurses, physician assistants, administrators, and others involved in cancer care and research.

    Clinical courses are offered in conjunction with Harvard Medical School, which is accredited by the Accreditation Council for Continuing Medical Education (ACCME). Harvard Medical School designates these educational activities as credit towards the AMA Physician's Recognition Award. Other courses are offered directly by Dana-Farber or by Partners HealthCare.

    Observerships

    We offer observerships for physicians to shadow clinicians in the Hematologic Malignancies, Stem Cell Transplantation, and Cellular Therapies programs. Observerships offer an opportunity to interact with our experts, shadow in outpatient clinics and other areas as approved by your sponsor, and participate in lab-based research.

    • Observership curricula and scheduling are managed by each department.
    • Interested candidates must have an identified attending physician sponsor. Interested candidates should contact a member of our Hematologic Malignancies, Stem Cell Transplant, or Cell Therapies programs to inquire about sponsorship.
    • Observership periods are two to four weeks in duration.
    • We offer observerships in our outpatient clinics only; there is no access to our inpatient hospital.
    • Application requirements:
      • CV, letter from home institution, observership fee
      • Participants must meet our health requirements, which include proof of certain immunizations.

    Email dana_martin@dfci.harvard.edu with questions about an observership with our Hematologic Malignancies, Stem Cell Transplant, or Cellular Therapies program.

    Stem Cell Transplantation and Cellular Therapies Annual Symposium

    This annual education program is for physicians, nurses, social workers, and payors who care for patients with cancer who may be appropriate for cellular therapy treatment. It features presentations and panel discussions about the rapidly emerging and evolving cellular therapies, with insight on eligibility, referral guidelines, and post-treatment management. Information for the 2023 fall event will be posted this summer.

    Subscribe to "Advances in Hematologic Malignancies," a free biannual eNewsletter providing updates about Dana-Farber Brigham Cancer Center’s hematologic oncology research and care, current clinical trials, and upcoming CME programs.